School of Medicine

Pain management researchers at the School of Medicine are recruiting people who have had shingles to test the effectiveness of an investigational drug designed to reduce the severe pain that can last for months or years after a bout with the disorder.

In an effort to learn about the latest research and treatments for amytrophic lateral sclerosis (ALS) and other nervous system diseases, the widow of Hans Vonk, former music director of the St. Louis Symphony Orchestra, will tour the newly established Hope Center for Neurological Disorders at the School of Medicine on Monday, Nov. 15.

Originating in Washington University research laboratories, St. Louis-based biotechnology company Apath has generated enough profit in just seven years to contribute $1 million in royalty payments back to the School of Medicine.

General asthma rates have been steadily rising, but the most dramatic increases have occurred among urban youth.

At stake are researchers’ efforts to find new ways to reduce loss of vision, kidney failure, heart damage and other diabetes side effects.

“Stated in the most basic terms, we are studying why some people are fat and some are skinny,” says lead investigator Ingrid B. Borecki.

Photo by Mary ButkusChancellor Mark S. Wrighton is presented with a plaque designating the former Cori laboratory as a National Historic Chemical Landmark.

School of Medicine researchers found that gut microbes promote fat storage by suppressing the production of a certain protein. More medical articles

“The world, and neurosurgery, has lost an outstanding physician, mentor and scientist,” colleague Robert L. Grubb says.

The former volunteer professor of pediatrics died Oct. 21 of pneumonia.